Expression and regulation of G1 cell-cycle inhibitors (p16(INK4A), p15(INK4B), p18(INK4C), p19(INK4D) in human acute myeloid leukemia and normal myeloid cells

Leukemia

Volumn 11, Issue 1, 1997, Pages 54-63

  Schwaller, J ^a   Pabst, Th ^a   Koeffler, H P ^b   Niklaus, G ^a   Loetscher, P ^a   Fey, M F ^a   Tobler, A ^a,c  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF BERN   (Switzerland)

Author keywords

Acute myeloid leukemia; Cell cycle inhibitor; Myeloid differentiation

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR; MESSENGER RNA; PHORBOL ESTER; PROTEIN P16; CARRIER PROTEIN; CDKN2B PROTEIN, HUMAN; CDKN2C PROTEIN, HUMAN; CDKN2D PROTEIN, HUMAN; CELL CYCLE PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 2B; CYCLIN DEPENDENT KINASE INHIBITOR 2C; CYCLIN DEPENDENT KINASE INHIBITOR 2D; ENZYME INHIBITOR; PROTEIN P16INK4A; TUMOR PROTEIN; TUMOR SUPPRESSOR PROTEIN;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; BONE MARROW CULTURE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL DIFFERENTIATION; CELL STRAIN HL 60; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GRANULOCYTE; HEMATOPOIESIS; HUMAN; HUMAN CELL; MITOSIS INHIBITION; MONOCYTE; MULTIGENE FAMILY; NORTHERN BLOTTING; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR GENE; ACUTE DISEASE; CELL CULTURE; GENETICS; METABOLISM; MYELOID LEUKEMIA;

ACUTE DISEASE; CARRIER PROTEINS; CELL CYCLE PROTEINS; CELL DIFFERENTIATION; CYCLIN-DEPENDENT KINASE INHIBITOR P15; CYCLIN-DEPENDENT KINASE INHIBITOR P16; CYCLIN-DEPENDENT KINASE INHIBITOR P18; CYCLIN-DEPENDENT KINASE INHIBITOR P19; ENZYME INHIBITORS; G1 PHASE; GENE EXPRESSION REGULATION, LEUKEMIC; GRANULOCYTES; HL-60 CELLS; HUMANS; LEUKEMIA, MYELOID; MONOCYTES; NEOPLASM PROTEINS; RNA, MESSENGER; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS;

EID: 0030614549     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2400522     Document Type: Article

References (15)

1. 1 cyclins. Cell 1990; 73: 1059-1063.
2. Morgan DO. Principles of CDK regulation. Science 1995; 374: 131-134.
3. Hunter T, Pines J. Cyclins and cancer II: cyclin D and CDK inhibitors come of age. Cell 1994; 79: 573-582.
4. Hirama T, Koeffler HP. Role of cyclin-dependent kinase inhibitors in the development of cancer. Blood 1995; 86: 841-854.
5. El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW, Vogelstein B. WAF-1, a potential mediator of p53 tumor suppression. Cell 1993; 75: 817-825.
6. Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 1994; 78: 59-66.
7. CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene. Genes Dev 1995; 9: 650-662.
8. Serrano M, Hannon GJ, Beach D. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 1993; 66: 704-707.
9. Hannon GJ, Beach D. p15INK4B is a potential effector of TGF-β-induced cell cycle arrest. Nature 1994; 371: 257-261.
10. INK4A in human cancer. Proc Natl Acad Sci USA 1994; 91: 11045-11049.
11. Takeuchi S, Bartram CR, Seriu T, Miller CW, Tobler A, Janssen JWG, Reiter A, Ludwig WD, Zimmermann M, Schwaller J, Lee E, Miyoshi I, Koeffler HP. Analysis of a family of cyclin-dependent kinase inhibitors: p15/MTS2/INK4B, p16/MTS1/INK4A, and p18 genes in acute lymphoblastic leukemia of childhood. Blood 1995; 86: 755-760.
12. Sill H, Goldman JM, Cross NCP. Homozygous deletions of the p16 tumor-suppressor gene are associated with lymphoid trans-formation of chronic myeloid leukemia. Blood 1995; 85: 2013-2016.
13. INK4BMTS2 in human leukemias and lymphomas. Cancer Res 1995; 55: 1436-1440.
14. Serrano M, Lee H-W, Chin L, Cordon-Cardoso C, Beach D, DePhino RA. Role of the INK4a locus in tumor suppression and cell mortality. Cell 1996; 85: 27-37.
15. Quelle DE, Zindy F, Ashumun RA, Sherr CJ. Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest. Cell 1996; 83: 993-1000.